Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two ...

Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance ...

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

He cited a study that found that although the U.S. has the costliest healthcare system in the world, it ranks 42nd in life ...

Novo Nordisk’s (NVO) blockbuster diabetes drug Ozempic may have a potential link with an eye condition that causes vision ...

Novo Nordisk A/S’s blockbuster shot Ozempic was linked to an increased risk of a rare form of vision loss in a study that ...

Sydney Sweeney silenced internet trolls who criticized her body by sharing footage of her intense workout sessions—and the ...

It’s quickly become evident that GLP-1 drugs for diabetes, weight loss, and more are the new wonder drugs—if only people ...

Doctors might be slow to admit it, but Ozempic and other GLP-1 drugs are making dieting and exercise obsolete.

A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...

Musk's plan to cut $2 trillion in federal spending could clash with his proposal to subsidize a drug costing up to $1,000 a ...